Fig. 1
Schematic diagram of the experimental design: (a) pharmacokinetics study of midazolam (MDZ) during extracorporeal membrane oxygenation (ECMO) and (b) investigation of CYP3A activity and expression during ECMO.
Fig. 1 | Scientific Reports
Schematic diagram of the experimental design: (a) pharmacokinetics study of midazolam (MDZ) during extracorporeal membrane oxygenation (ECMO) and (b) investigation of CYP3A activity and expression during ECMO.
